[Immunosuppression by Treg can be decreased with anti-GARP antibodies].
Institut de Duve, avenue Hippocrate, 74, 1200 Bruxelles, Belgique.
Sophie
S
Lucas
D000906:Antibodies / Q000494:pharmacology* / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology*; D007167:Immunotherapy / Q000379:methods*; D008565:Membrane Proteins / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000276:immunology
D000906:Antibodies; D019496:Cancer Vaccines; C087215:LRRC32 protein, human; D008565:Membrane Proteins